Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the structure of PPAR was clarified, three PPAR isoforms (PPARα, PPARγ, and PPARδ) have been identified, each of which is encoded by a separate gene [21].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [21]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Self-citationA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
The c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Self-citation
Research works printed but not linked: 8
- Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
- Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
- Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
- Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
- Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
- Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
- Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
- Current Protocols in Molecular Biology (Wiley, New York, 1990).
Cited by
Items 901–1,000 of 1,011
Gupta, M., Mahajan, V. K., Mehta, K. S., Chauhan, P. S., & Rawat, R. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1571-1 · Cited by 80
“1990 as receptors that induced proliferation of rodent peroxisomes in response to various xenobiotic compounds [36].”
BackgroundThe Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke
Pereira, M. P., Hurtado, O., Cárdenas, A., Alonso-Escolano, D., Boscá, L., Vivancos, J., Nombela, F., Leza, J. C., Lorenzo, P., Lizasoain, I., et al. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000178852.83680.3c · Cited by 76
Stunes, A. K., Westbroek, I., Gustafsson, B. I., Fossmark, R., Waarsing, J. H., Eriksen, E. F., Petzold, C., Reseland, J. E., & Syversen, U. (2011) · BMC Endocrine Disorders · doi:10.1186/1472-6823-11-11 · Cited by 76
“Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors, and exist as three different subtypes in mammals (PPARa, PPARδ and PPARg (with isoforms g1, g2 and g3)) [1,2].”
BackgroundSolanes, G., Pedraza, N., Iglesias, R., Giralt, M., & Villarroya, F. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0395 · Cited by 75
Theocharis, S. E., Kanelli, H., Politi, E. N., Margeli, A. P., Karkandaris, C., Philipides, T., & Koutselinis, A. S. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00013-2 · Cited by 84
“[7] Issermann I, Green S.”
BackgroundTranscriptional regulation of metabolic processes: implications for cardiac metabolism
van Bilsen, M., Vusse, G. J., & Reneman, R. S. (1998) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050739 · Cited by 85
“These transcription factors were discovered as receptors for certain drugs, including clofibrate [ 40 ], which have been used clinically to treat hyperlipidemia.”
BackgroundMuga, S. J., Thuillier, P., Pavone, A., Rundhaug, J. E., Boeglin, W. E., Jisaka, M., BRASH, A. R., & Fischer, S. M. (2000) · PubMed · Cited by 87
Staels, B., & Auwerx, J. (1992) · Development · doi:10.1242/dev.115.4.1035 · Cited by 76
The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat
(1992) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1992.0012 · Cited by 77
Self-citationBanner, C., Göttlicher, M., Widmark, E., Sjövall, J., Rafter, J., & Gustafsson, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36951-0 · Cited by 76
Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease
Choudhary, N. S., Kumar, N., & Duseja, A. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.06.004 · Cited by 73
Anti-Obesity Effect of Fish Oil and Fish Oil-Fenofibrate Combination in Female KK Mice
Arai, T., Kim, H.-J., Chiba, H., & Matsumoto, A. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.1313 · Cited by 74
Yu, B.-C., Chang, C.-K., Ou, H., Cheng, K., & Cheng, J.-T. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn172 · Cited by 80
“Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcriptional factors that regulate expression of genes involved in fatty acid uptake and oxidation, lipid metabolism, and inflammation.(12) The three subtypes of PPARs, specifically PPARa, PPARg, and PPARd (or PPARb), have distinct tissue dist…”
BackgroundPPARγ as a metabolic regulator: insights from genomics and pharmacology
Savage, D. B. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405008793 · Cited by 82
Knauf, C., Rieusset, J., Foretz, M., Cani, P. D., Uldry, M., Hosokawa, M., Martinez, E., Bringart, M., Waget, A., Kersten, S., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1536 · Cited by 72
Macrophage-derived lipid agonists of PPAR-αas intrinsic controllers of inflammation
Pontis, S., Ribeiro, A., Sasso, O., & Piomelli, D. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1092944 · Cited by 81
“Peroxisome proliferator-activated receptor-a Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear receptor superfamily (Issemann & Green, 1990).”
BackgroundTranscriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
Tan, N. S., Vázquez‐Carrera, M., Montagner, A., Sng, M. K., Guillou, H., & Wahli, W. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.001 · Cited by 83
Draft toxicological profile for perfluoroalkyls
Cadore, A., Chou, C.-Y., Jones, D. G., Llados, F., & Pohl, H. R. (2009) · Cited by 80
A Unique Population: Adipose-Resident Regulatory T Cells
Zeng, Q., Sun, X., Xiao, L., Xie, Z., Bettini, M., & Deng, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02075 · Cited by 70
“The name PPAR is derived from the first identified member of the family, PPARα, which has the ability to respond to various compounds that induce peroxisome proliferation (28).”
BackgroundRoberts‐Thomson, S. J. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00921.x · Cited by 79
“dtd" [ ]> Introduction The peroxisome proliferator-activated receptors (PPAR) were discovered in the early 1990s by Issemann and Green”
Misra, P., Owuor, E. D., Li, W., Yu, S., Qi, C., Meyer, K., Zhu, Y.-J., Rao, M. S., Kong, A.-N. T., & Reddy, J. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208829200 · Cited by 81
Characterization of a 190-Kilobase Pair Domain of Human Type I Hair Keratin Genes
Rogers, M. A., Winter, H., Wolf, C., Heck, M., & Schweizer, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26683 · Cited by 75
Dallongeville, J., Baugé, E., Tailleux, A., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008809200 · Cited by 75
Target acquired: Selective autophagy in cardiometabolic disease
Evans, T. D., Sergin, I., Zhang, X., & Razani, B. (2017) · Science Signaling · doi:10.1126/scisignal.aag2298 · Cited by 74
Ciana, P., Biserni, A., Tatangelo, L., Tiveron, C., Sciarroni, A. F., Ottobrini, L., & Maggi, A. C. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0152 · Cited by 78
Cimini, A., & Cerù, M. P. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9024-2 · Cited by 78
“After the isolation of PPARα (NR1C1) as the receptor mediating peroxisome proliferation in rodent hepatocytes [19], two related isotypes, PPARβ/δ (NR1C2; referred to as PPARβ herein) and PPARγ (NR1C3), have been characterized [20].”
BackgroundPPAR α in Obesity: Sex Difference and Estrogen Involvement
Yoon, M. (2010) · PPAR Research · doi:10.1155/2010/584296 · Cited by 80
“Both PPARα and ERs belong to the nuclear hormone receptor superfamily, which has a typical structure consisting of six functional domains, A/B, C, D, and E/F (Figure 1) [29– 31].”
BackgroundYessoufou, A., Hichami, A., Besnard, P., Moutairou, K., & Khan, N. A. (2006) · Endocrinology · doi:10.1210/en.2006-0067 · Cited by 71
Tan, C. K., Zhuang, Y., & Wahli, W. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1280467 · Cited by 70
“Since their discovery in the early 1990s [40,112], PPARs have been the subject of relentless investigation.”
BackgroundCardiac nuclear receptors: architects of mitochondrial structure and function
Vega, R. B., & Kelly, D. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88888 · Cited by 76
Fish primary hepatocyte culture; an important model for xenobiotic metabolism and toxicity studies
Pesonen, M., & Andersson, T. B. (1997) · Aquatic Toxicology · doi:10.1016/s0166-445x(96)00811-9 · Cited by 81
Clarke, S. D., Turini, M. E., & Jump, D. Β. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90494-4 · Cited by 74
Olivier, L., & Krisans, S. K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00139-6 · Cited by 85
Antagonism of the Actions of Peroxisome Proliferator-activated Receptor-α by Bile Acids
Sinal, C. J., Yoon, M., & Gonzalez, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107000200 · Cited by 75
Diep, Q. N., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.38.2.249 · Cited by 80
Brisson, D., Ledoux, K., Bossé, Y., St‐Pierre, J., Julien, P., Perron, P., Hudson, T. J., Vohl, M., & Gaudet, D. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00007 · Cited by 81
Wan, Y.-J. Y., Cai, Y., Lungo, W., Fu, P., Locker, J., French, S., & Sucov, H. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000934200 · Cited by 74
Hunter, J. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03717-9 · Cited by 74
Roberts, R. A. (1999) · Archives of Toxicology · doi:10.1007/s002040050629 · Cited by 74
“Role of PPARa in the rodent response to PPs In 1990, a receptor that mediates the e ects of PPs, the peroxisome proliferator activated receptor alpha (PPARa) was cloned and sequenced (Issemann and Green 1990).”
BackgroundPeroxisome proliferator-activated receptors and the metabolic syndrome
Bragt, M. C. E., & Popeijus, H. E. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.053 · Cited by 80
MEUNIER-DURMORT, C., POIRIER, H., NIOT, I., FOREST, C., & BESNARD, P. (1996) · Biochemical Journal · doi:10.1042/bj3190483 · Cited by 74
PPARα deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins
Lindén, D., Alsterholm, M., Wennbo, H., & Oscarsson, J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31509-1 · Cited by 73
Selective activation of PPARγ in breast, colon, and lung cancer cell lines
Allred, C. D., & Kilgore, M. W. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.02.003 · Cited by 73
Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARα
Roberts, R. A., James, N. H., Hasmall, S. C., Holden, P. R., Lambe, K. G., Macdonald, N., West, D., Woodyatt, N. J., & Whitcome, D. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00243-x · Cited by 80
Gurnell, M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.10.001 · Cited by 84
Nomura, M., Tanase, T., Ide, T., Tsunoda, M., Suzuki, M., Uchiki, H., Murakami, K., & Miyachi, H. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205144 · Cited by 73
MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers
Portius, D., Sobolewski, C., & Foti, M. (2017) · PPAR Research · doi:10.1155/2017/7058424 · Cited by 74
“AP-1: Activator protein-1 ApoA: Apolipoprotein-A BAT: Brown adipose tissue CD36: Cluster of differentiation 36 FAT: Fatty acid translocase C/EBP𝛼: CCAAT/enhancer-binding protein 𝛼 C. elegans: Caenorhabditis elegans COX-2: Cyclooxygenase-2 CRC: Colorectal carcinoma CREB: cAMP response element-binding protein CVD: Cardi…”
BackgroundHinds, T. D., Kipp, Z. A., Xu, M., Yiannikouris, F. B., Morris, A. J., Stec, D. F., Wahli, W., & Stec, D. E. (2021) · Cells · doi:10.3390/cells11010004 · Cited by 76
“Despite it being over three decades since the discovery of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) [1], its role in extrahepatic tissues remains ambiguous.”
BackgroundMeadus, W. J., MacInnis, R. J., & Dugan, M. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280079 · Cited by 72
“The PPAR proteins are expressed throughout the body and are the target of a variety of lipidaemic and insulin sensitizing drugs.”
BackgroundInfluentialPPARα and the regulation of cell division and apoptosis
Roberts, R. A., Chevalier, S., Hasmall, S. C., James, N. H., Cosulich, S. C., & Macdonald, N. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00275-5 · Cited by 72
Bremer, J. (2001) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00004-2 · Cited by 78
Edgar, A. D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T., & Barouki, R. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00042-3 · Cited by 71
PPARγ1 as a Molecular Target of Eicosapentaenoic Acid in Human Colon Cancer (HT-29) Cells1,
Allred, C. D., Talbert, D. R., Southard, R. C., Wang, X., & Kilgore, M. W. (2008) · Journal of Nutrition · doi:10.1093/jn/138.2.250 · Cited by 74
Aboud, O. A., Wettersten, H. I., & Weiss, R. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071115 · Cited by 71
“PPARa is a ligand-activated transcription factor that belongs to the nuclear hormone receptor superfamily [22].”
BackgroundMeadus, W. J. (2003) · Biological Procedures Online · doi:10.1251/bpo43 · Cited by 71
“Ultimately however, even protein levels may not reflect actual gene activity due to post-translational modifications; therefore, the PPRE responsive genes, adipocyte fatty acid binding protein (AFBAP) and acyl Co A oxidase (ACO), were measured to confirm PPAR activity with its transcription rate.”
BackgroundInfluentialHepatic Steatosis and Peroxisomal Fatty Acid Beta-oxidation
Cherkaoui‐Malki, M., Surapureddi, S., Hajj, H. I. E., Vamecq, J., & Andreoletti, P. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762765 · Cited by 74
Yamashita, S., Masuda, D., & Matsuzawa, Y. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48918 · Cited by 66
Fux, C., Mitta, B., Kramer, B. P., & Fussenegger, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh001 · Cited by 77
PPARs in Inflammation, Atherosclerosis and Thrombosis
Duez, H., Fruchart, J., & Staels, B. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800402 · Cited by 77
Peroxisome proliferator-activated receptors: Lipid binding proteins controling gene expression
van Bilsen, M., Vusse, G. J., Gilde, A. J., Lindhout, M., & van der Lee, K. A. J. M. (2002) · Springer eBooks · doi:10.1007/978-1-4419-9270-3_17 · Cited by 72
Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans
Hertz, R., & Bar‐Tana, J. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00290-2 · Cited by 71
Glycerolipid biosynthesis in peroxisomes (microbodies)
Hajra, A. K. (1995) · Progress in Lipid Research · doi:10.1016/0163-7827(95)00013-5 · Cited by 71
Fourcade, S., Savary, S., Albet, S., Gauthé, D., Gondcaille, C., Pineau, T., Bellenger, J., Bentejac, M., Holzinger, A., Berger, J., et al. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02249.x · Cited by 70
Misra, P., & Reddy, J. K. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.011 · Cited by 71
“Accordingly, PPARa is highly expressed in tissues with active fatty acid catabolism, such as liver, heart, kidney, brown fat and muscle [17].”
Guo, L., Fang, H., Collins, J., Fan, X.-H., Dial, S., Wong, A., Mehta, K., Blann, E., Shi, L., Tong, W., et al. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-s2-s18 · Cited by 69
“, fatty acid and their metabolites) [5,14].”
Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
Lefere, S., Steenkiste, C. V., Verhelst, X., Vlierberghe, H. V., Devisscher, L., & Geerts, A. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2222-1 · Cited by 77
“Unsurprisingly, it has since long been an attractive pharmacological target [93], and promising new PPAR agonists are currently being developed for the treatment of metabolic disorders [94].”
BackgroundOkine, B. N., Gaspar, J. C., & Finn, D. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14339 · Cited by 70
“Three major isoforms have been identified: PPARα, cloned from mouse liver (Issemann and Green, 1990), PPARβ/δ and PPARγ, both cloned from Xenopus (Dreyer et al.”
BackgroundPPARγ Activation Attenuates Opioid Consumption and Modulates Mesolimbic Dopamine Transmission
de Guglielmo, G., Melis, M., Luca, M. A. D., Kallupi, M., Li, H. W., Niswender, K. D., Giordano, A., Senzacqua, M., Somaini, L., Cippitelli, A., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.268 · Cited by 74
“…discovered as orphan nuclear receptors in the early 1990s, PPARs were found to be targets of a group of compounds known as peroxisome proliferators (Issemann and Green, 1990) because of their ability to induce the proliferation of cellular organelle peroxisomes; specifically through activation of…”
BackgroundEnergy metabolism and cytotoxicity
Portilla, D. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00088-3 · Cited by 73
Keller, J. M., Collet, P., Bianchi, A., Huin‐Schohn, C., Krémarik, P., Bécuwe, P., Schohn, H., Domenjoud, L., & Dauça, M. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11032176 · Cited by 82
“A screen for novel nuclear receptor cDNAs in the liver of fibrate-treated mice identified a clone encoding a molecule which was able to be activated by PPs in a transient transfection assay (Issemann and Green, 1990).”
Cancio, I., Orbea, A., Völkl, A., Fahimi, H. D., & Cajaraville, M. P. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8358 · Cited by 70
Modulation of mitogenesis by liver fatty acid binding protein
Sorof, S. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00666102 · Cited by 70
“involved in these multiple biochemical responses to peroxisome proliferators has gained substantial support from the discovery of the mouse peroxisome proliferator-activated receptor (PPAR) by Green and coworkers [94-97].”
BackgroundTranscription, adipocyte differentiation, and obesity
Auwerx, J. H., Martin, G., Guerre-Millo, M., & Staels, B. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00210629 · Cited by 74
Molecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation
Bugge, A., & Mandrup, S. (2010) · PPAR Research · doi:10.1155/2010/169506 · Cited by 69
“The founding member of the family, PPARα, was identified in 1990 and named by its ability to become activated by chemicals known to induce peroxisome proliferation in rodents [1].”
BackgroundPeroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
Wagner, N., & Wagner, K. (2022) · Cells · doi:10.3390/cells11152432 · Cited by 73
Obesity-induced chronic low-grade inflammation in adipose tissue: A pathway to Alzheimer’s disease
Zhai, W., Meng, Z., Chunxiao, W., Lingjie, M., Anguo, Z., Zhang, Y., Xinran, C., Yanjiao, X., & Li, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102402 · Cited by 76
“PPARs are transcription factors of the nuclear hormone receptor superfamily that regulate energy metabolism (Issemann and Green, 1990).”
BackgroundVasko, R. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6666 · Cited by 81
“The receptor responsible for this effect was later iden-tified and named PPAR a (39, 50).”
Brooks, D. A., Etgen, G. J., Rito, C. J., Shuker, A. J., Dominianni, S. J., Warshawsky, A. M., Ardecky, R., Paterniti, J. R., Tyhonas, J., Karanewsky, D. S., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0155188 · Cited by 73
Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line
Bishop‐Bailey, D., Hla, T., & Warner, T. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703628 · Cited by 68
“In ECV304 cells we have previously used transient transfections with the pACO.g.Luc (Bishop-Bailey & Hla, 1999); a plasmid that contains the rat acyl CoA PPRE linked to drive the expression of luciferase (Tugwood et al., 1992; Roberts et al., 1998; Issemann & Green, 1990).”
BackgroundMethodLampen, A., Zimnik, S., & Nau, H. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00014-0 · Cited by 70
Peroxisome proliferator-activated receptor gamma agonists in renal disease
Iglesias, P., & Díez, J. J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02134 · Cited by 71
Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle
Cresci, S., Wright, L. D., Spratt, J. A., Briggs, F. N., & Kelly, D. P. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1413 · Cited by 68
Very Long Chain and Long Chain Acyl-CoA Thioesterases in Rat Liver Mitochondria
Svensson, T., Alexson, S. E. H., & Hiltunen, J. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12177 · Cited by 69
Urbańska, K., Pannizzo, P., Grabacka, M., Croul, S. E., Valle, L. D., Khalili, K., & Reiss, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23588 · Cited by 71
“PPARs are nuclear receptors, which belong to the superfamily of steroid hormone receptors.(16) Their transcriptional activity after ligand activation is associated with the formation of heterodimers with the retinoid X receptors and binding to the specific DNA sequences.”
BackgroundSyversen, U., Stunes, A. K., Gustafsson, B. I., Obrant, K. J., Nordsletten, L., Berge, R. K., Thommesen, L., & Reseland, J. E. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-10 · Cited by 79
“Background Peroxisome proliferator activated receptors (PPARs) are nuclear transcription factors that modulate the expression of a variety of genes involved in lipid metabolism and fat storage [1-3].”
Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism
Oh, K.-J., Park, J., Lee, S. Y., Hwang, I., Kim, J. B., Park, T.-S., Lee, H.-J., & Koo, S.-H. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00502.2010 · Cited by 68
Yee, L. D., Young, D. C., Rosol, T. J., VanBuskirk, A. M., & Clinton, S. K. (2005) · Journal of Nutrition · doi:10.1093/jn/135.5.983 · Cited by 76
Wu, J., Tsai, H. D., Cheung, W.-M., Hsu, C. Y., & Lin, T. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9294-z · Cited by 70
Jones, D. C., Ding, X., Zhang, T. Y., & Daynes, R. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.196 · Cited by 68
“T he peroxisome proliferator-activated receptor (PPAR )(3) is a member of the nuclear hormone receptor superfamily that was initially described for its ability to induce peroxisome proliferation in rodent hepatocytes in response to certain xenobiotic compounds (1).”
BackgroundOu, Y., Yang, C., Cheng, C., Raung, S., Hung, Y.-Y., & Chen, C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.071 · Cited by 68
Neuroprotective effects of PPARγ agonists against oxidative insults in HT-22 cells
Aoun, P., Watson, D. G., & Simpkins, J. W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01867-3 · Cited by 72
Mechanisms of Peroxisome Proliferation by Perfluorooctanoic Acid and Endogenous Fatty Acids
Intrasuksri, U., Rangwala, S. M., O'Brien, O., Noonan, D. J., & Feller, D. R. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00029-9 · Cited by 68
MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response
Kilgore, M. W., Tate, P. L., Rai, S., Sengoku, E., & Price, T. M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04057-4 · Cited by 76
Regulation of Peroxisome Proliferator-Activated Receptors
Sørensen, H. N., Treuter, E., & Gustafsson, J.-Å. (1998) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60924-3 · Cited by 74
Cajaraville, M. P., Orbea, A., Marigómez, I., & Cancio, I. (1997) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(97)00057-1 · Cited by 68
Peroxisome degradation in mammals: mechanisms of action, recent advances, and perspectives
Nordgren, M., Wang, B., Apanasets, O., & Fransen, M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00145 · Cited by 67
“…accepted that the localization and activity of many proteins (e.g., kinases, phosphatases, transcription factors, etc.) are reversibly controlled by the cellular composition and concentration of specific lipids and (redox-derived) signaling mediators (Hekimi et al., 2011; Schug et al., 2012).”
BackgroundClay, C. E., Namen, A. M., Atsumi, G.-I., Trimboli, A. J., Fonteh, A. N., High, K. P., & Chilton, F. H. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.33786 · Cited by 67
Kiaei, M. (2008) · PPAR Research · doi:10.1155/2008/418765 · Cited by 67
“PPARs regulate the expression of target genes, in particular those associated with lipid metabolism [7–9].”
Foll, B. L., Ciano, P. D., Panlilio, L. V., Goldberg, S. R., & Ciccocioppo, R. (2013) · Current Drug Targets · doi:10.2174/1389450111314070006 · Cited by 70
“Originally discovered as orphan nuclear receptors in the early 1990s, PPARs were found to be targets of a group of compounds known as peroxisome proliferators (14) due to their ability to induce a proliferation of cellular organelle peroxisomes in rodents (15).”
BackgroundPPARγ ablation sensitizes proopiomelanocortin neurons to leptin during high-fat feeding
Long, L., Toda, C., Jeong, J. K., Horváth, T. L., & Diano, S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76220 · Cited by 71
Metadata
- Authors
- Issemann, I., & Green, S.
- Venue
- Nature
- Published
- 1990-10
- Volume
- 347
- Issue
- 6294
- Pages
- 645-650
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066092624
- Cited by
- 3,519
- References
- 56
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 47 · 2022: 58 · 2021: 71 · 2020: 63 · 2019: 82 · 2018: 74 · 2017: 90 · 2016: 87 · 2015: 94 · 2014: 98 · 2013: 106 · 2012: 133
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- peroxisome proliferator-activated receptors, steroid hormone receptors, ligand-activated transcription factors, peroxisome proliferation, hepatocarcinogens, hypolipidemic effect, cancer risk, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Hypolipidemic Agents, Base Sequence, Binding Sites, Cloning, Molecular, DNA, Humans, Liver, Liver Neoplasms, Experimental, Microbodies, Molecular Sequence Data, Nafenopin, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.